The successful completion of a clinical trial is generally seen as a positive development for a pharmaceutical company. It suggests that the drug being tested is effective and could potentially lead to regulatory approval and commercialization, which would increase the company's revenues and profitability. Therefore, this news could have a positive impact on Acurx Pharmaceuticals' stock price in the short term.